DSP Healthcare Fund
- NAV
- ₹50.00
- —30 Oct 2026
- AUM (₹ Cr)
- 3,721
- Average, July - September 2026
- Expense ratio
- 0.75%
- Regular 2.05%
- Risk
- Very High
- SEBI riskometer
- 1Y return
- 15.0%+4.2%
- Benchmark 10.8%
- 3Y CAGR
- 21.6%-1.1%
- Benchmark 22.7%
- 5Y CAGR
- 16.2%+0.8%
- Benchmark 15.4%
Rank in category
#5 of 8 Healthcare funds on its 1-, 3- and 5-year returns together.
Ranked on 1Y, 3Y and 5Y together. 8 of 19 funds have a rank here; it needs a 5-year record. Direct plan, growth option. Click a column to rank by it.
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily NAVs. Risk-free rate 6.5% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| Fund | 0.0% | +1.4% | +15.2% | +14.9% | +15.0% | +21.6% | +16.2% | — | +22.5% |
| BSE Healthcare TRI | — | — | — | — | 10.8% | 22.7% | 15.4% | — | 17.8% |
| Healthcare average | -0.3% | -0.9% | 13.5% | 16.7% | 14.5% | 22.4% | 16.1% | 14.7% | 16.3% |
| Difference | — | — | — | — | +4.2% | -1.1% | +0.8% | — | +4.7% |
Portfolio
Valuation
- P/E
- 39.6
- Covers 88% of its shares
- Category median
- 48.4
- 19 Healthcare funds
- Benchmark P/E
- 44.3
- BSE Healthcare
P/E is the value of the shares the fund holds, at the close of 30 Oct 2026, over their profit in the last four reported quarters (the owners' share from continuing operations, consolidated where filed, losses included), weighted by the fund's portfolio disclosed 21 Oct 2026. US shares (3% of the fund) are valued from their own filings. The category median is worked out the same way; the benchmark's is the index provider's own figure on the same basis.
Fund details
- Fund house
- DSP Mutual Fund
- Category
- Equity · Healthcare
- SEBI classification
- Equity / Sectoral / Thematic
- Benchmark
- BSE Healthcare TRI
- Launch date
- 3 Dec 2018 (7.9 years)
- Structure
- Open Ended
- Plans and options
- Direct Growth, Regular Growth
- Fund manager
- Chirag Dagli
- Minimum SIP
- ₹100
- Minimum lumpsum
- ₹100 (then ₹100)
- Exit load
- 0.50%
- Lock-in
- None
- Riskometer
- Very High (benchmark Very High)
- Expense ratio as of
- 29 Oct 2026
- AUM period
- July - September 2026
- ISIN, Direct Growth
- INF740KA1LG1
- ISIN, Regular Growth
- INF740KA1LD8
- Scheme code
- 145454, 145456
NAV and returns as of 30 Oct 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.
Other healthcare funds
Other funds in the Healthcare category.
- Mirae Asset Healthcare FundMirae Asset Mutual Fund · ₹3,458 Cr · ER 0.62%5Y 16.6%
- HDFC Pharma and Healthcare FundHDFC Mutual Fund · ₹3,128 Cr · ER 1.05%
- Tata India Pharma & Healthcare FundTata Mutual Fund · ₹1,534 Cr · ER 1.09%5Y 14.9%
- UTI - Healthcare FundUTI Mutual Fund · ₹1,399 Cr · ER 1.33%5Y 16.2%
- Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Mutual Fund · ₹1,076 Cr · ER 1.07%5Y 14.8%
- WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital Mutual Fund · ₹858 Cr · ER 1.07%